LakeShore Biopharma Enters Financing Lease Agreement
Ticker: LSBWF · Form: 6-K · Filed: May 6, 2025 · CIK: 1946399
| Field | Detail |
|---|---|
| Company | Lakeshore Biopharma CO., LTD. (LSBWF) |
| Form Type | 6-K |
| Filed Date | May 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financing-lease, subsidiary, foreign-private-issuer
TL;DR
Lakeshore Biopharma (fka YishengBio) just signed a financing lease deal via its Liaoning subsidiary.
AI Summary
LakeShore Biopharma Co., Ltd. (formerly YS Biopharma Co., Ltd. and YishengBio Co., Ltd.) entered into a financing lease agreement through its subsidiary, Liaoning Yisheng Biotechnology Co., Ltd. The company is a foreign private issuer filing a Form 6-K for the month of May 2025. Its principal executive offices are located in Beijing, PRC.
Why It Matters
This filing indicates a new financing arrangement for LakeShore Biopharma, which could impact its capital structure and operational flexibility.
Risk Assessment
Risk Level: low — The filing is a routine report of a financing lease agreement, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- LakeShore Biopharma Co., Ltd. (company) — Registrant
- YS Biopharma Co., Ltd. (company) — Former Company Name
- YishengBio Co., Ltd (company) — Former Company Name
- Liaoning Yisheng Biotechnology Co., Ltd (company) — Subsidiary entering lease agreement
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a report of foreign private issuer for the month of May 2025, specifically detailing the entry into a financing lease agreement by the Company through its subsidiary.
What are the former names of LakeShore Biopharma Co., Ltd.?
LakeShore Biopharma Co., Ltd. was formerly known as YS Biopharma Co., Ltd. (name change on March 10, 2023) and YishengBio Co., Ltd. (name change on September 12, 2022).
Where are LakeShore Biopharma's principal executive offices located?
The company's principal executive offices are located at Building No. 2, 38 Yongda Road, Daxing Biomedical Industry Park, Daxing District, Beijing, PRC.
Which subsidiary entered into the financing lease agreement?
The financing lease agreement was entered into by the Company through its subsidiary, Liaoning Yisheng Biotechnology Co., Ltd.
Does LakeShore Biopharma file annual reports under Form 20-F or Form 40-F?
LakeShore Biopharma indicates it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 6, 2025 regarding LakeShore Biopharma Co., Ltd. (LSBWF).